Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA)
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 151, 13-20
Abstract
No abstract availableKeywords
Funding Information
- NIH (T32 DA015040, K05 DA031246, P51 OD011132)
- AFIP (2015/25482-3)
- FAPESP
- National Institute on Drug Abuse
- National Institute on Alcohol Abuse and Alcoholism
This publication has 60 references indexed in Scilit:
- Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyJournal of Psychopharmacology, 2012
- Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administrationBehavioural Pharmacology, 2011
- Drug Wanting: Behavioral Sensitization and Relapse to Drug-Seeking BehaviorPharmacological Reviews, 2011
- Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in OthersBiological Psychiatry, 2010
- Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in ratsPsychopharmacology, 2010
- Endocrine and Neurochemical Effects of 3,4-Methylenedioxymethamphetamine and Its Stereoisomers in Rhesus MonkeysThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Oxytocin and the neural mechanisms regulating social cognition and affiliative behaviorFrontiers in Neuroendocrinology, 2009
- The incentive sensitization theory of addiction: some current issuesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose bingesNeuroscience, 2008
- Chronic treatment with a serotonin2 receptor (5-HT2R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]Drug and Alcohol Dependence, 2006